These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15762972

  • 1. Fetal fibronectin as predictor of successful induction of mid-trimester abortion.
    Mercorio F, Mercorio A, Votino C, Di Spiezio Sardo A, Barba GV, Nappi C.
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):390-4. PubMed ID: 15762972
    [Abstract] [Full Text] [Related]

  • 2. [Gameprost, sulproston and dinoproston for induced abortion in the 15th-24th week of pregnancy].
    Kamali P, Hohmann M, Herrero J, Künzel W.
    Zentralbl Gynakol; 1998 Apr; 120(6):293-300. PubMed ID: 9659700
    [Abstract] [Full Text] [Related]

  • 3. [Does para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?].
    Winkler M, Wolters S, Funk A, Rath W.
    Zentralbl Gynakol; 1997 Apr; 119(12):621-4. PubMed ID: 9483814
    [Abstract] [Full Text] [Related]

  • 4. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L.
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [Abstract] [Full Text] [Related]

  • 5. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA, Ayala Méndez JA, Jiménez Solís G, Aguilar Gutiérrez F, Díaz Cueto L.
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [Abstract] [Full Text] [Related]

  • 6. [Premature termination of pregnancy in the 2nd and 3rd trimester. Serial administration of 1 mg gemeprost vaginal suppositories versus intravenous sulproston].
    Müller T, Backe J, Rempen A.
    Geburtshilfe Frauenheilkd; 1996 May; 56(5):234-8. PubMed ID: 8768060
    [Abstract] [Full Text] [Related]

  • 7. [Termination of pregnancy in the 2nd trimester by serial administration of gemeprost vaginal suppositories. A prospective study (corrected)].
    Krauss T, Rath W, Cunze T.
    Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):623-6. PubMed ID: 8719005
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M, Ghidini A, Korker V, Pezzullo JC.
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [Abstract] [Full Text] [Related]

  • 10. Cervical fetal fibronectin as a predictor of first trimester pregnancy outcome in unexplained recurrent miscarriage.
    Mercorio F, Mercorio A, Di Spiezio Sardo A, Votino C, Barba GV, Nappi C.
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun 01; 126(2):165-9. PubMed ID: 16256259
    [Abstract] [Full Text] [Related]

  • 11. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.
    Gemzell-Danielsson K, Ostlund E.
    Acta Obstet Gynecol Scand; 2000 Aug 01; 79(8):702-6. PubMed ID: 10949238
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of dinoprostone gel and gemeprost suppositories for induction of abortion in the second and third trimester].
    Mink D, Heiss C, Rothbrust S, Schmidt W.
    Zentralbl Gynakol; 1995 Aug 01; 117(5):263-8. PubMed ID: 7793169
    [Abstract] [Full Text] [Related]

  • 13. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.
    Shennan A, Jones G, Hawken J, Crawshaw S, Judah J, Senior V, Marteau T, Chinn S, Poston L.
    BJOG; 2005 Mar 01; 112(3):293-8. PubMed ID: 15713142
    [Abstract] [Full Text] [Related]

  • 14. Cervical fluid oncofetal fibronectin as a predictor of early ectopic pregnancy. Is it affected by blood contamination?
    Shimoya K, Hashimoto K, Shimizu T, Koyama M, Azuma C, Murata Y.
    J Reprod Med; 2002 Aug 01; 47(8):640-4. PubMed ID: 12216430
    [Abstract] [Full Text] [Related]

  • 15. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
    Duhig KE, Chandiramani M, Seed PT, Briley AL, Kenyon AP, Shennan AH.
    BJOG; 2009 May 01; 116(6):799-803. PubMed ID: 19432568
    [Abstract] [Full Text] [Related]

  • 16. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J, Chedraui P, Hidalgo L, Medina M.
    J Matern Fetal Neonatal Med; 2009 Feb 01; 22(2):89-93. PubMed ID: 19085632
    [Abstract] [Full Text] [Related]

  • 17. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM, Fox NS, Chasen ST.
    J Perinat Med; 2008 Feb 01; 36(3):202-5. PubMed ID: 18576928
    [Abstract] [Full Text] [Related]

  • 18. Termination of third-trimester pregnancy before term with gemeprost vaginal pessaries.
    Frambach T, Müller T, Blissing S, Sütterlin M, Dietl J.
    Acta Obstet Gynecol Scand; 2002 Jun 01; 81(6):523-6. PubMed ID: 12047305
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF, Javed I, Shuja S, Shoaib T, Bano K, Waheed S, Ansar A.
    J Coll Physicians Surg Pak; 2006 Jul 01; 16(7):464-7. PubMed ID: 16827957
    [Abstract] [Full Text] [Related]

  • 20. Assessment of rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I, Marek S, Hellmeyer L, Reitz D, Schmidt S.
    Obstet Gynecol; 2005 Feb 01; 105(2):280-4. PubMed ID: 15684152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.